1500.2000 -25.60 (-1.68%)
NSE Dec 30, 2025 15:31 PM
Volume: 320.0K
 

1500.20
-1.68%
Prabhudas Lilladhar
Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...
Eris Lifesciences Ltd. is trading below all available SMAs
More from Eris Lifesciences Ltd.
Recommended